Sexually Transmitted Diseases

Bacterial Vaginosis

American College of Obstetricians & Gynecologists. (2020). ACOG Practice Bulletin Number 215. Vaginitis in nonpregnant patients. Obstetrics & Gynecology, 135(1), e1-e17. doi: 10.1097/AOG.0000000000003604

Bagnall, P & Rizzolo, D. (2017). Bacterial vaginosis: A practical review. Journal of the American Academy of Physician Assistants, 30(12), 15-21. doi: 10.1097/01.JAA.0000526770.60197.fa

Bradshaw, C. S., & Sobel, J. D. (2016). Current treatment of bacterial vaginosis—limitations and need for innovation. The Journal of Infectious Diseases, 214(Suppl 1), S14-S20. doi: 10.1093/infdis/jiw159

Centers for Disease Control and Prevention. (2020). Bacterial vaginosis-CDC Fact Sheet. https://www.cdc.gov/std/bv/stdfact-bacterial-vaginosis.htm

Centers for Disease Control and Prevention. (2015). Bacterial vaginosis. 2015 Sexually transmitted disease treatment guidelines. https://www.cdc.gov/std/tg2015/bv.htm

Hollier, A. (Ed.). (2018). Bacterial vaginosis. In Clinical Guidelines in Primary Care. (3rd ed.) Advanced Practice Education Associates.

Jones, A. (2019). Bacterial vaginosis: A review of treatment, recurrence, and disparities. The Journal for Nurse Practitioners, 15(6), 420-423. DOI: https://doi.org/10.1016/j.nurpra.2019.03.010

Van Schalkwyk, J., Yudin, M. H., & Infectious Disease Committee. (2015). Vulvovaginitis: Screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis. Journal of Obstetrics and Gynaecology Canada, 37(3), 266-274. doi:10.1016/S1701-2163(15)30316-9

Chlamydia

Centers for Disease Control and Prevention. (2017). Chlamydia. https://www.cdc.gov/std/chlamydia/default.htm

Centers for Disease Control and Prevention. (2015). Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommendations and Reports, 64 (No. RR-3),1-137. https://www.cdc.gov/std/tg2015/default.htm

Centers for Disease Control and Prevention. (2019). Sexually transmitted diseases surveillance 2018. https://www.cdc.gov/std/stats18/

National Center for Health Statistics. (2017). National Center for Health Statistics Reports. No. 105. Condom use during sexual intercourse among women and men aged 15-44 in the United States: 2011-2015 National Survey of Family Growth. https://www.cdc.gov/nchs/data/nhsr/nhsr105.pdf

U.S. Preventive Services Task Force. (2014). Final Recommendation Statement: Chlamydia and Gonorrhea Screening. https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/chlamydia-and-gonorrhea-screening

Genital Herpes

Agyemang, E., Le, Q. A., Warren, T., Magaret, A. S., Selke, S., Johnston, C., Jerome, K. R., Wald, A. (2017.) Performance of commercial enzyme-linked immunoassays for diagnosis of herpes simplex virus-1 and herpes simplex virus-2 infection in a clinical setting. Sexually Transmitted Diseases, 44 (12),763-767. doi: 10.1097/OLQ.0000000000000689.

Ayoade, F. O. (2018). Herpes simplex. Medscape. https://emedicine.medscape.com/article/218580-overview

Centers for Disease Control and Prevention. (2016). Genital herpes treatment and care. https://www.cdc.gov/std/herpes/treatment.htm

Finger-Jardim, F., Avila, E. C., da Hora, V. P., Gonçalves, C. V., de Martinez, A. M. B., Soares, M. A. (2017.) Prevalence of herpes simplex virus types 1 and 2 at maternal and fetal sides of the placenta in asymptomatic pregnant women. American Journal of Reproductive Immunology, 78(1). doi: 10.1111/aji.12689

Ramchandani, M., Selke, S., Magaret, A., Barnum, G., Huang, M. W., Corey, L., Wald, A. (2017.) Prospective cohort study showing persistent HSV-2 shedding in women with genital herpes 2 years after acquisition. Sexually Transmitted Infections. doi: 10.1136/sextrans-2017-053244

Thellman, N. M., Triezenberg, S. J. (2017.) Herpes simplex virus establishment, maintenance, and reactivation: in vitro modeling of latency. Pathogens, 6(3), E28. doi: 10.3390/pathogens6030028

World Health Organization. (2020.) Herpes simplex virus. http://www.who.int/mediacentre/factsheets/fs400/en/

Gonorrhea

Centers for Disease Control and Prevention. (2020). Expedited Partner Therapy (EPT). http://www.cdc.gov/std/ept/

Centers for Disease Control and Prevention. (2019). Sexually transmitted disease surveillance 2018. https://www.cdc.gov/std/stats18/

Centers for Disease Control and Prevention. (2018). Gonorrhea. https://www.cdc.gov/std/stats17/gonorrhea.htm

Kirkcaldy, R., Harvey, A, Papp J., del Rio, C., Soge, O., Holmes, K., Hook, E., … Torrone, E. (2016). Neisseria gonorrhoeae antimicrobial susceptibility surveillance — The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. MMWR Surveillance Summary, 65(No. SS-7),1-19. DOI: http://dx.doi.org/10.15585/mmwr.ss6507a1external icon

Wi, T., Lahra, M. M., Ndowa, F., Bala, M., Dillon, J., Ramon-Pardo, P., et al. (2017). Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action. PLoS Med 14(7), e1002344. https://doi.org/10.1371/journal.pmed.1002344

Wong, B., Chandrasekar, P., Ammar, N., et al. (2018). Gonorrhea treatment and management. Medscape. http://emedicine.medscape.com/article/218059-treatment

Human Papillomavirus

Aldahan, A. S., Mlacker, S., Shah, V. V., Kamath, P., Alsaidan, M., Samarkandy, S., & Nouri, K. (2016). Efficacy of intralesional immunotherapy for the treatment of warts: A review of the literature. Dermatologic Therapy, 29(3), 197-207. doi:10.1111/dth.12352

Centers for Disease Control and Prevention. (2019). HPV and cancer. https://www.cdc.gov/cancer/hpv/statistics/cases.htm

Centers for Disease Control and Prevention. (2019). HPV vaccine schedule and dosing. https://www.cdc.gov/hpv/hcp/schedules-recommendations.html

Centers for Disease Control and Prevention. (2019). Human papillomavirus statistics. https://www.cdc.gov/std/hpv/stats.htm

Chaturvedi, A. K., Graubard, B. I., Broutian, T., Pickard, R. K. L., Tong, Z. Y., Xiao, W., Kahle, L., Gillison, M. L. (2017.) Effect of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the United States. Journal of Clinical Oncology. doi: 10.1200/JCO.2017.75.0141

Ghelardi, A., Parazzini, F., Martella, F., Pieralli, A., Bay, P., Tonetti, A., . . . Joura, E. A. (2018). SPERANZA project: HPV vaccination after treatment for CIN2. Gynecologic Oncology, 151(2), 229-234. doi:10.1016/j.ygyno.2018.08.033

Han, J. J., Tarney, C. M., & Song, J. (2017). Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA. Future Oncology, 13(13), 1129-1132. doi:10.2217/fon-2017-0147

Kidd L. C., Chaing, S., Chipollini, J., Giuliano, A. R., Spiess, P. E., Sharma, P. (2017.) Relationship between human papillomavirus and penile cancer-implications for prevention and treatment. Translational Andrology & Urology, 6(5),791-802. doi: 10.21037/tau.2017.06.27.

McQuillan, G., Kruszon-Moran, D., Markowitz, L. E., Unger, E. R., & Paulose-Ram, R. (2017). Prevalence of HPV in adults Aged 18-69: United States, 2011-2014. NCHS Data Brief (280), 1-8. https://www.ncbi.nlm.nih.gov/pubmed/28463105

Nelson, V. M., & Benson, A. B. (2017). Epidemiology of anal canal cancer. Surgery and Oncology Clinics of North America, 26(1), 9-15. doi:10.1016/j.soc.2016.07.001

Reusser, N. M., Downing, C., Guidry, J., & Tyring, S. K. (2015). HPV carcinomas in immunocompromised patients. Journal of Clinical Medicine, 4(2), 260-281. doi:10.3390/jcm4020260

Ronco, G., Franceschi, S. (2017.) Cervical cancer screening: the transformational role of routine human papillomavirus testing. Annals of Internal Medicine, 168(2), 75-76. doi: 10.7326/M17-2872

Serrano, B., Brotons, M., Bosch, F. X., & Bruni, L. (2018). Epidemiology and burden of HPV-related disease. Best Practice & Research, Clinical Obstetrics and Gynaecology, 47, 14-26. doi:10.1016/j.bpobgyn.2017.08.006

U.S. Preventive Services Task Force, Curry, S. J., Krist, A. H., Owens, D. K., Barry, M. J., Caughey, A. B., . . . Wong, J. B. (2018). Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA, 320(7), 674-686. doi:10.1001/jama.2018.10897

Van Dyne, E. A., Henley, S. J., Saraiya, M., Thomas, C. C., Markowitz, L. E., & Benard, V. B. (2018). Trends in human papillomavirus-associated cancers , United States, 1999-2015. MMWR Morbity and Mortality Weekly Reports, 67(33), 918-924. doi:10.15585/mmwr.mm6733a2

Vegunta, S., Files, J. A., & Wasson, M. N. (2017). Screening women at high risk for cervical cancer: special groups of women who require more frequent screening. Mayo Clinic Proceedings, 92(8), 1272-1277. doi:10.1016/j.mayocp.2017.06.007

Workowski, K. A., Bolan, G. A., Centers for Disease Control & Prevention. (2015). Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommendations and Reports, 64(RR-03), 1-137. https://www.ncbi.nlm.nih.gov/pubmed/26042815

Pelvic Inflammatory Disease

American College of Obstetricians and Gynecologists. (2019). Patient Resources: Pelvic inflammatory disease. https://www.acog.org/patient-resources/faqs/gynecologic-problems/pelvic-inflammatory-disease

Centers for Disease Control and Prevention. (2017). Pelvic inflammatory disease (PID) treatment and care. https://www.cdc.gov/std/pid/treatment.htm

Centers for Disease Control and Prevention. (2017). Pelvic inflammatory disease (PID) statistics. http://www.cdc.gov/std/pid/stats.htm

Centers for Disease Control and Prevention. (2015). Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommendations and Reports, 64(No. RR-3), 1-137. https://www.cdc.gov/std/tg2015/default.htm

Curtis, K. M., Tepper, N. K, Jatlaoui, T. C, et al. (2016). U.S. Medical Eligibility Criteria for Contraceptive Use. MMWR Recommendations and Reports, 65(No. RR-3), 1-104. doi: http://dx.doi.org/10.15585/mmwr.rr6503a1. https://www.cdc.gov/mmwr/volumes/65/rr/rr6503a1.htm

Jennings, L. K., Krywko, D. M. (2019). Pelvic inflammatory disease. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK499959/

Syphilis

Brian Euerly, M. F., Bronze, M. S., & Hogan, D. J. (2017). Syphilis differential diagnoses. Medscape. https://emedicine.medscape.com/article/229461-differential

Centers for Disease Control and Prevention. (2020). Expedited partner therapy (EPT). http://www.cdc.gov/std/ept/

Centers for Disease Control and Prevention. (2015). 2015 STD Treatment Guidelines: Syphilis. https://www.cdc.gov/std/tg2015/syphilis.htm

Rac, M. W., Bryant, S., Cantey, J., McIntire, D., Sheffield, J. (2015). Maternal titers after adequate syphilotherapy during pregnancy. Cinical Infectious Disease, 60(5): 686-690. doi: 10.1093/cid/ciu920

Ramsey, P. S. (2014). Editorial commentary: Post-syphilotherapy titers in pregnancy. https://cid.oxfordjournals.org/content/60/5/691.full

Stafford, I. A., Berra, A., Minard, C. G., Fontenot, V., Kopkin, R. H., Rodrigue, E., … Hill, J. B. (2019). Challenges in the contemporary management of syphilis among pregnant women in New Orleans, LA. Infectious Diseases in Obstetrics & Gynecology, 1-7. https://doi.org/10.1155/2019/2613962

U.S. Preventive Services Task Force. (2016). Final recommendation statement. Syphilis infection in nonpregnant adults and adolescents: screening. https://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/syphilis-infection-in-nonpregnant-adults-and-adolescents

Trichomoniasis

Bouchemal, K., Bories, C., Loiseau, P. M. (2017). Strategies for prevention and treatment of trichomonas vaginalis infections. Clinical Microbiology Reviews, 30(3), 811-825. doi: 10.1128/CMR.00109-16

Centers for Disease Control & Prevention. (2015). Sexually transmitted diseases treatment guidelines. Trichomoniasis. http://www.cdc.gov/std/tg2015/trichomoniasis.htm

Centers for Disease Control and Prevention. (2015). Sexually transmitted diseases treatment guidelines. MMWR Recommendations and Reports, 64(No. RR-3), 1-137.

Howe, K., Kissinger, P. (2017). Single-dose compared with multidose metronidazole for the treatment of trichomoniasis in women: a meta-analysis. Sexually Transmitted Diseases, 44(1), 29-34. doi: 10.1097/OLQ.0000000000000537

Sexually Transmitted Diseases

Didn't find what you were looking for?